Search

Your search keyword '"Takano, Masashi"' showing total 517 results
Start Over Author "Takano, Masashi" Publication Year Range Last 10 years
517 results on '"Takano, Masashi"'

1. Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study

Author

Nagao, Shoji, Nishio, Shin, Takehara, Kazuhiro, Sato, Shinya, Satoh, Toyomi, Shimada, Muneaki, Yamaguchi, Satoshi, Tanabe, Hiroshi, Takano, Masashi, Horie, Kouji, Takei, Yuji, Imai, Yuichi, Hibino, Yumi, Hasegawa, Kosei, Takekuma, Munetaka, Nakamura, Kazuto, Takano, Hirokuni, Fujiwara, Keiichi, and Masuyama, Hisashi

Published
2024
Full Text
View/download PDF

5. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group

Author

Kikuchi, Akira, Yoshida, Hiroshi, Tsuda, Hitoshi, Nishio, Shin, Suzuki, Shiro, Takehara, Kazuhiro, Kino, Nao, Sumi, Toshiyuki, Kato, Kazuyoshi, Yokoyama, Masatoshi, Nakamura, Kazuto, Takano, Masashi, Sato, Shinya, Kato, Hisamori, Tamate, Masato, Horie, Koji, Kato, Tomoyasu, Sakamoto, Atsuhiko, Fukunaga, Masaharu, Kaku, Tsunehisa, Yoshida, Masayuki, Yaegashi, Nobuo, and Satoh, Toyomi

Published
2023
Full Text
View/download PDF

17. Uterine serous carcinoma

Author

Bogani, Giorgio, Ray-Coquard, Isabelle, Concin, Nicole, Ngoi, Natalie Y.L., Morice, Philippe, Enomoto, Takayuki, Takehara, Kazuhiro, Denys, Hannelore, Nout, Remi A., Lorusso, Domenica, Vaughan, Michelle M., Bini, Marta, Takano, Masashi, Provencher, Diane, Indini, Alice, Sagae, Satoru, Wimberger, Pauline, Póka, Robert, Segev, Yakir, Kim, Se Ik, Candido dos Reis, Francisco J., Lopez, Salvatore, Mariani, Andrea, Leitao, Mario M., Jr, Raspagliesi, Francesco, Panici, Pieluigi Benedetti, Di Donato, Violante, Muzii, Ludovico, Colombo, Nicoletta, Scambia, Giovanni, Pignata, Sandro, and Monk, Bradley J.

Published
2021
Full Text
View/download PDF

18. On-tissue polysulfide visualization by surface-enhanced Raman spectroscopy benefits patients with ovarian cancer to predict post-operative chemosensitivity

Author

Honda, Kazufumi, Hishiki, Takako, Yamamoto, Sohei, Yamamoto, Takehiro, Miura, Nami, Kubo, Akiko, Itoh, Mai, Chen, Wei-Yu, Takano, Masashi, Yoshikawa, Tomoyuki, Kasamatsu, Takahiro, Sonoda, Shinichiro, Yoshizawa, Hirotoshi, Nakamura, Seigo, Itai, Yuichiro, Shiota, Megumi, Koike, Daisuke, Naya, Masayuki, Hayakawa, Noriyo, Naito, Yoshiko, Matsuura, Tomomi, Iwaisako, Keiko, Masui, Toshihiko, Uemoto, Shinji, Nagashima, Kengo, Hashimoto, Yoshinori, Sakuma, Tomohiro, Matsubara, Osamu, Huang, Wilber, Ida, Tomoaki, Akaike, Takaaki, Masugi, Yohei, Sakamoto, Michiie, Kato, Tomoyasu, Ino, Yoshinori, Yoshida, Hiroshi, Tsuda, Hitoshi, Hiraoka, Nobuyoshi, Kabe, Yasuaki, and Suematsu, Makoto

Published
2021
Full Text
View/download PDF

19. 2α-Substituted Vitamin D Derivatives Effectively Enhance the Osteoblast Differentiation of Dedifferentiated Fat Cells.

Author

Ishizawa, Michiyasu, Takano, Masashi, Kittaka, Atsushi, Matsumoto, Taro, and Makishima, Makoto

Subjects
*VITAMIN D, *VITAMIN D receptors, *FAT cells, *TISSUE differentiation, *ENZYME inactivation, *CELL differentiation, *REGENERATIVE medicine
Abstract

The active form of vitamin D3, 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3], is a principal regulator of calcium homeostasis through activation of the vitamin D receptor (VDR). Previous studies have shown that 2α-(3-hydroxypropyl)-1,25D3 (O1C3) and 2α-(3-hydroxypropoxy)-1,25D3 (O2C3), vitamin D derivatives resistant to inactivation enzymes, can activate VDR, induce leukemic cell differentiation, and increase blood calcium levels in rats more effectively than 1,25(OH)2D3. In this study, to further investigate the usefulness of 2α-substituted vitamin D derivatives, we examined the effects of O2C3, O1C3, and their derivatives on VDR activity in cells and mouse tissues and on osteoblast differentiation of dedifferentiated fat (DFAT) cells, a cell type with potential therapeutic application in regenerative medicine. In cell culture experiments using kidney-derived HEK293 cells, intestinal mucosa-derived CaCO2 cells, and osteoblast-derived MG63 cells, and in mouse experiments, O2C2, O2C3, O1C3, and O1C4 had a weaker effect than or equivalent effect to 1,25(OH)2D3 in VDR transactivation and induction of the VDR target gene CYP24A1, but they enhanced osteoblast differentiation in DFAT cells equally to or more effectively than 1,25(OH)2D3. In long-term treatment with the compound without the medium change (7 days), the derivatives enhanced osteoblast differentiation more effectively than 1,25(OH)2D3. O2C3 and O1C3 were more stable than 1,25(OH)2D3 in DFAT cell culture. These results indicate that 2α-substituted vitamin D derivatives, such as inactivation-resistant O2C3 and O1C3, are more effective than 1,25(OH)2D3 in osteoblast differentiation of DFAT cells, suggesting potential roles in regenerative medicine with DFAT cells and other multipotent cells. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

20. A case of low-grade endometrial stromal sarcoma presented as an intramyometrial mass mimicking uterine leiomyoma on MRI

Author

Tamada, Soichiro, primary, Edo, Hiromi, additional, Sakima, Taishi, additional, Tanaka, Ryo, additional, Shikata, Kohei, additional, Nishitani, Soko, additional, Miyamoto, Morikazu, additional, Takano, Masashi, additional, Kuboshima, Keisuke, additional, Miyai, Kosuke, additional, Ogata, Sho, additional, and Shinmoto, Hiroshi, additional

Published
2023
Full Text
View/download PDF

26. A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes

Author

Ishikawa, Mitsuya, Kasamatsu, Takahiro, Tsuda, Hitoshi, Fukunaga, Masaharu, Sakamoto, Atsuhiko, Kaku, Tsunehisa, Kato, Tatsuya, Takahashi, Kazuaki, Ariyoshi, Kazuya, Suzuki, Kayo, Arimoto, Takahide, Matsumoto, Yoshinari, Nakai, Hidekatsu, Inoue, Takafumi, Yokoyama, Masatoshi, Kawabata, Takayo, Kodama, Shoji, Miyamoto, Tsutomu, Takano, Masashi, and Yaegashi, Nobuo

Published
2019
Full Text
View/download PDF

32. A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)

Author

Fujiwara, Hiroyuki, Ushijima, Kimio, Nagao, Shoji, Takei, Yuji, Shimada, Muneaki, Takano, Masashi, Yoshino, Kiyoshi, Kawano, Yoshiaki, Hirashima, Yasuyuki, Nagase, Satoru, Nishio, Shin, Nishikawa, Tadaaki, Ito, Kimihiko, Shoji, Tadahiro, Kimura, Eizo, Takano, Tadao, Sugiyama, Toru, Kigawa, Junzo, Fujiwara, Keiichi, and Suzuki, Mitsuaki

Published
2019
Full Text
View/download PDF

33. The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology Group study (JGOG3016A1)

Author

Murakami, Ryusuke, Matsumura, Noriomi, Michimae, Hirofumi, Tanabe, Hiroshi, Yunokawa, Mayu, Iwase, Haruko, Sasagawa, Motoi, Nakamura, Toshiaki, Tokuyama, Osamu, Takano, Masashi, Sugiyama, Toru, Sawasaki, Takashi, Isonishi, Seiji, Takehara, Kazuhiro, Nakai, Hidekatsu, Okamoto, Aikou, Mandai, Masaki, and Konishi, Ikuo

Published
2019
Full Text
View/download PDF

34. Gestational choriocarcinoma

Author

Bogani, Giorgio, primary, Ray-Coquard, Isabelle, additional, Mutch, David, additional, Vergote, Ignace, additional, Ramirez, Pedro T, additional, Prat, Jaime, additional, Concin, Nicole, additional, Ngoi, Natalie Yan Li, additional, Coleman, Robert L, additional, Enomoto, Takayuki, additional, Takehara, Kazuhiro, additional, Denys, Hannelore, additional, Lorusso, Domenica, additional, Takano, Masashi, additional, Sagae, Satoru, additional, Wimberger, Pauline, additional, Segev, Yakir, additional, Kim, Se Ik, additional, Kim, Jae-Weon, additional, Herrera, Fernanda, additional, Mariani, Andrea, additional, Brooks, Rebecca A, additional, Tan, David, additional, Paolini, Biagio, additional, Chiappa, Valentina, additional, Longo, Mariangela, additional, Raspagliesi, Francesco, additional, Benedetti Panici, Pierluigi, additional, Di Donato, Violante, additional, Caruso, Giuseppe, additional, Colombo, Nicoletta, additional, Pignata, Sandro, additional, Zannoni, Gianfranco, additional, Scambia, Giovanni, additional, and Monk, Bradley J, additional

Published
2023
Full Text
View/download PDF

37. Clear Cell Carcinoma

Author

Takano, Masashi, Takakura, Satoshi, Fujiwara, Keiichi, Pujade-Lauraine, Eric, editor, Ray-Coquard, Isabelle, editor, and Lécuru, Fabrice, editor

Published
2017
Full Text
View/download PDF

43. Data from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

44. Supplementary Table 3 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

45. Supplementary Table 5 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

46. Supplementary Table 2 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

47. Supplementary Table 6 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

48. Supplementary Figure 8 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

49. Supplementary Table 1 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

50. Supplementary Figure 2 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results